25 research outputs found

    Kidney health for everyone everywhere - from prevention to detection and equitable access to care

    Get PDF
    The global burden of chronic kidney disease (CKD) is rapidly increasing, with a projection of becoming the 5th most common cause of years of life lost globally by 2040. Aggravatingly, CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. Crucially, however, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions – be it primary, secondary or tertiary. This article focuses on outlining and analyzing measures that can be implemented in every country to promote and advance CKD prevention. Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tract, as well as exposure to environmental risk factors and nephrotoxins. In persons with pre-existing kidney disease, secondary prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to support the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management and treatment are often lacking. Hence, there is an urgent need to increase the awareness of the importance of preventive measures among populations, professionals and policy makers

    The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dataset.

    Get PDF
    There is an epidemic of chronic kidney disease (CKD) clustering in rural communities, predominantly in a number of low- and middle-income countries. 1 Tens of thousands of working-aged adults are estimated to have died from the disease in Central America 2 with similar numbers in Sri Lanka. 3 Similar diseases have been reported elsewhere, such as rural regions or communities in India and North and West Africa. Those affected do not have common risk factors or underlying conditions that lead to CKD, such as diabetes, immune-mediated glomerulonephritis, or structural renal disease. In instances where histopathology is available, the predominant feature is tubular atrophy and interstitial fibrosis. Although it is currently unclear whether there is a unified underlying cause, these conditions have been collectively termed CKD of unknown cause (CKDu). Other terms used include “CKD of nontraditional cause,” “Mesoamerican nephropathy,” “chronic intestinal nephritis in agricultural communities,” and “kidney disease of unknown cause in agricultural laborers,” but we have chosen CKDu as the most agnostic terminology
    corecore